Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Novel Phoenix® Therapy Developed to Treat PTSD

Evren Technologies developed Phoenix®, a novel therapy for the treatment of Post-traumatic Stress Disorder (PTSD).

The Phoenix® is an earbud device which delivers a light electrical tingle to activate vagus nerve consisting of a calming effect on the body and also helps in reducing the symptoms of PTSD.

The device helps in delivering transcutaneous auricular vagal nerve stimulation (taVNS) in a discreet earbud design.

Phoenix earbud device provides personalized medicine by addressing underlying autonomic imbalance of PTSD by bringing transcutaneous auricular vagal nerve stimulation (taVNS) in a closed-loop system.

Phoenix® - Revolutionary Transcutaneous Auricular Vagus Nerve Therapy has granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) to treat Post-traumatic Stress Disorder (PTSD).

Annually 7.5 million Americans undergo treatment for PTSD. Moreover, due to COVID shutdown PTSD rates have tripled.

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024